Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
JUPITER NEUROSCIENCES, INC. | Director | Convertible Notes | 10.8K | $30.2K | $2.80 | Jan 22, 2025 | Direct |
Alaunos Therapeutics, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 13.7K | Aug 18, 2025 | Direct | ||
JUPITER NEUROSCIENCES, INC. | Director | Common Stock, par value $0.0001 per share | 10.8K | Jan 22, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRT | Alaunos Therapeutics, Inc. | Aug 18, 2025 | 1 | $0 | 4 | Aug 20, 2025 | Chief Executive Officer, Director |
TCRT | Alaunos Therapeutics, Inc. | Jul 2, 2025 | 1 | $0 | 4 | Jul 7, 2025 | Chief Executive Officer, Director |
TCRT | Alaunos Therapeutics, Inc. | Apr 13, 2025 | 1 | $0 | 4 | Apr 15, 2025 | Director |
JUNS | JUPITER NEUROSCIENCES, INC. | Jan 22, 2025 | 2 | -$30.2K | 4 | Jan 24, 2025 | Director |
JUNS | JUPITER NEUROSCIENCES, INC. | Nov 8, 2024 | 0 | $0 | 3 | Nov 8, 2024 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
TCRT | ZIOPHARM ONCOLOGY INC | Sep 1, 2021 | 1 | $91.5K | 4 | Sep 3, 2021 | Director |